Valproic acid ameliorates C. elegans dopaminergic neurodegeneration with implications for ERK-MAPK signaling

Neuroscience Letters

Volumn 541, Issue , 2013, Pages 116-119

  Kautu, Bwarenaba B ^a   Carrasquilla, Alejandro ^a   Hicks, Matthew L ^a   Caldwell, Kim A ^a,b,c   Caldwell, Guy A ^a,b,c  

^a UNIVERSITY OF ALABAMA   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Caenorhabditis; Dopamine; ERK MAPK; Neurodegeneration; RNAi; Valproic acid

Indexed keywords

ALPHA SYNUCLEIN; MITOGEN ACTIVATED PROTEIN KINASE; VALPROIC ACID;

ARTICLE; CAENORHABDITIS ELEGANS; DOPAMINERGIC NERVE CELL; GENE OVEREXPRESSION; GENETIC ANALYSIS; NEMATODE; NERVE CELL; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; ORTHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ALPHA-SYNUCLEIN; ANIMALS; ANTICONVULSANTS; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; DOPAMINERGIC NEURONS; HUMANS; MAP KINASE KINASE 2; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; PARKINSON DISEASE; RNA INTERFERENCE; VALPROIC ACID;

EID: 84876416418     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.02.026     Document Type: Article

References (31)

1. Biermann J., Grieshaber P., Goebel U., Martin G., Thanos S., Giovanni S.D., Lagre'ze W.A. Valproic acid-mediated neuroprotection and regeneration in injured retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 2010, 51:526-534.
2. Brenner S. The genetics of Caenorhabditis elegans. Genetics 1974, 77:95-104.
3. Cao S., Gelwix C.C., Caldwell K.A., Caldwell G.A. Torsin-mediated protection from cellular stress in the dopaminergic neurons of Caenorhabditis elegans. J. Neurosci. 2005, 25:3801-3812.
4. Christian J., Ximenes M., Crisóstomo E., Verde L., Graça M., Viana G.S.B. Valproic acid a drug with multiple molecular targets related to its potential neuroprotective action. Neurosci. Med. 2012, 3:107-123.
5. Church D.L., Guan K.L., Lambie E.J. Three genes of the MAP kinase cascade mek-2, mpk-1/sur-1 and let-60 ras, are required for meiotic cell cycle progression in Caenorhabditis elegans. Development 1995, 121:2525-2535.
6. Di Daniel E., Mudge A.W., Maycox P.R. Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons. Bipolar Disord. 2005, 7:33-41.
7. Dauer W., Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003, 39:889-909.
8. Ferrer I., Blanco R., Carmona M., Puig B., Barrachina M., Gómez C., Ambrosio S. Active phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and dementia with Lewy bodies. J. Neural Transm. 2001, 108:1383-1396.
9. Hao Y., Creson T., Zhang L., Li P., Du F., Yuan P., Gould T.D., Manji H.K., Chen G. Mood stabilizer valproate promotes ERK pathway dependent cortical neuronal growth and neurogenesis. J. Neurosci. 2004, 24:6590-6599.
10. Harrington A.J., Yacoubian T.A., Slone S.R., Caldwell K.A., Caldwell G.A. Functional analysis of VPS41-mediated neuroprotection in Caenorhabditis elegans and mammalian models of Parkinson's disease. J. Neurosci. 2012, 32:2142-2153.
11. Hsuan S., Klintworth H.M., Xia Z. Basic fibroblast growth factor protects against rotenone-induced dopaminergic cell death through activation of extracellular signal-regulated kinases 1/2 and phosphatidylinositol-3 kinase pathways. J. Neurosci. 2006, 26:4481-4491.
12. Hunsberger J., Austin D.R., Henter I.D., Chen G. The neurotrophic and neuroprotective effects of psychotropic agents. Dialogues Clin. Neurosci. 2009, 11:333-348.
13. Iwata A., Maruyama M., Kanazawa I., Nukina N. Alpha-synuclein affects the MAPK pathway and accelerates cell death. J. Biol. Chem. 2001, 276:45320-45329.
14. Kamath S.R., Fraser A.G., Dong Y., Poulin G., Durbin R., Gotta M., Kanapink A., Bot N., Moreno S., Sohrmann M., Welchman D.P., Zipperlen P., Ahringer J. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 2003, 421:231-237.
15. Kidd S.K., Schneider J.S. Protective effects of valproic acid on the nigrostriatal dopamine system in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Neuroscience 2011, 194:189-194.
16. Lackner M.R., Kornfeld K., Miller L.M., Horvitz H.R., Kim S.K. MAP kinase homolog mpk-1, is involved in ras-mediated induction of vulval cell fates in Caenorhabditis elegans. Genes Dev. 1994, 8:160-173.
17. Lee M.H., Ohmachi S., Arur S., Nayak S., Franci R., Church D., Lambie E., Schedl T. Multiple functions and dynamic activation of MPK-1 extracellular signal-regulated kinase signaling in Caenorhabditis elegans germline development. Genetics 2007, 177:2039-2062.
18. Lin E., Cavanaugh J.E., Leak R.K., Perez R.G., Zigmond M.J. Rapid activation of ERK by 6-hydroxydopamine promotes survival of dopaminergic cells. J. Neurosci. Res. 2008, 86:108-117.
19. Locke C.J., Kautu B.B., Berry K.P., Lee S.K., Caldwell K.A., Caldwell G.A. Pharmacogenetic analysis reveals a post-developmental role for Rac GTPases in Caenorhabditis elegans GABAergic neurotransmission. Genetics 2009, 183:1357-1372.
20. Monti B., Gatta V., Piretti F., Raffaelli S.S., Virgili M., Contestabile A. Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease, involvement of α-synuclein. Neurotox. Res. 2010, 17:130-141.
21. Monti B., Mercatelli D., Contestabile A. Valproic acid neuroprotection in 6-OHDA lesioned rat, a model for Parkinson's disease. HOAJ Biol. 2012, 1:1-4.
22. Okuyama T., Inoue H., Ookuma S., Satoh T., Kano K., Hisamoto S., Hisamoto N., Matsumoto K., Nishida E. The ERK-MAPK pathway regulates longevity through SKN-1 and insulin-like signaling in Caenorhabditis elegans. J. Biol. Chem. 2010, 30274-30281.
23. Ostrerova N., Petrucelli L., Farrer M., Mehta N., Choi P., Hardy J., Wolozin B. Alpha-synuclein shares physical and functional homology with 14-3-3 proteins. J. Neurosci. 1999, 19:5782-5791.
24. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997, 276:2045-2047.
25. Singleton A.B., Farrer M., Johnson J., Singleton A., Hague S., Kachergus J., Hulihan M., Peuralinna T., Dutra A., Nussbaum R., Lincoln S., Crawley A., Hanson M., Maraganore D., Adler C., Cookson M.R., Muenter M., Baptista M., Miller D., Blancato J., Hardy J., Gwinn-Hardy K. Alpha-synuclein locus triplication causes Parkinson's disease. Science 2003, 302:841.
26. Waxman E.A., Giasson B.I. Molecular mechanisms of α-synuclein neurodegeneration. Biochim. Biophys. Acta 2009, 1792:616-624.
27. Wu Y., Han M. Suppression of activated let-60 ras protein defines a role of Caenorhabditis elegans Sur-1 MAP kinase in vulval differentiation. Genes Dev. 1994, 8:147-159.
28. Wu Y., Han M., Guan K.L. MEK-2, a Caenorhabditis elegans MAP kinase kinase, functions in Ras-mediated vulval induction and other developmental events. Genes Dev. 1995, 9:742-755.
29. Yan Z., Feng J., Fienburg A.A., Greengard P. D2 dopamine receptors induce mitogen-activated protein kinase and cAMP response element-binding protein phosphorylation in neurons. Proc. Natl. Acad. Sci. U.S.A. 1999, 196:11607-11612.
30. Yuan P., Huan L., Jian Y., Silvio J., Husseini G., Manji K., Chen G. The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth. J. Biol. Chem. 2001, 276:31674-31683.
31. Zhu J., Kulich S.M., Oury T.D., Chu C.T. Cytoplasmic aggregates of phosphorylated extracellular signal-regulated protein kinases in Lewy body diseases. Am. J. Pathol. 2002, 161:2087-2098.